Boehringer Ingelheim recently announced that it welcomes the international evidence-based 2015 ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary…
PatrĂcia Silva, PhD
PatrĂcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĂcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by PatrĂcia Silva, PhD
Researchers at University of Alabama at Birmingham (UAB) recently published in the Journal of Thoracic Disease,…
Researchers at the Spanish National Cancer Centre (CNIO) and the Complutense University of Madrid in Spain discovered that…
Dr. Dinesh Khanna from the University of Michigan Health System recently presented at the European League Against Rheumatism…
A new study recently published in the journal PLoS One reported data on a specific imaging tool…
A study recently published in the journal PloS One revealed that patients with acute exacerbations of idiopathic…
Triciribine Drug Able to Halt Progression of Pulmonary Fibrosis and Pulmonary Hypertension in Mice
Researchers at the University of Georgia and the Georgia Regents University discovered that the drug triciribine can halt…
The Medical Advisory Board of the Pulmonary Fibrosis Foundation (PFF)Â recently released an announcement regarding therapies based on stem…
Researchers at the Medical School of Nanjing University in China recently published in the journal Respirology findings…
Clinical stage biotech company Promedior Inc. will present data from its ongoing phase 2 clinical trial of their lead investigational therapy candidate…